A randomized, controlled field study to assess the efficacy and safety of lotilaner flavored chewable tablets (Credelio™) in eliminating fleas in client-owned dogs in the USA

BACKGROUND: Preclinical studies have shown that the novel isoxazoline, lotilaner (Credelio™, Elanco) administered orally to dogs, produces rapid flea and tick knockdown and sustained speed of kill for at least a month post-treatment with a wide safety margin. A field study was undertaken to validate...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Parasit Vectors
Autors principals: Karadzovska, Daniela, Chappell, Kimberly, Coble, Shane, Murphy, Martin, Cavalleri, Daniela, Wiseman, Scott, Drake, Jason, Nanchen, Steve
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2017
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5664423/
https://ncbi.nlm.nih.gov/pubmed/29089063
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13071-017-2469-x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars